Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancerBent Bruun Kristensen, Jonas Bergh, Bent Ejlertsen et al.|Acta Oncologica|2008Cited by 71
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifenJohan Rosell, John Carstensen, Bo Nordenskjöld et al.|Acta Oncologica|2017Cited by 32
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-upJohan Rosell, John Carstensen, Bo Nordenskjöld et al.|Breast Cancer Research and Treatment|2013Cited by 30
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trialJohan Rosell, John Carstensen, Bo Nordenskjöld et al.|British Journal of Cancer|2011Cited by 9
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapyAnna Nordenskjöld, Bo Nordenskjöld, Helena Fohlin et al.|The Breast|2023Cited by 7